US Stock MarketDetailed Quotes

SRPT Sarepta Therapeutics

Watchlist
  • 60.700
  • +1.210+2.03%
Trading Apr 24 11:52 ET
5.89BMarket Cap25.94P/E (TTM)

Sarepta Therapeutics Options Chain

ITM/OTM
All
Strike Price
All
15min Delay
609Call
89:11
77Put
Open Interest
Turnover
Volume
Chg
% Chg
Price
Ask
Bid
Strike Price
Bid
Ask
Price
% Chg
Chg
Volume
Turnover
Open Interest

0

-

-

-

-

-

-

-

-

-

1

-

-

-

-

-

-

-

-

-

1

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

6

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

2

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

17

-

-

-

-

-

-

-

-

-

43

-

-

-

-

-

-

-

-

-

8

-

-

-

-

-

-

-

-

-

12

-

-

-

-

-

-

-

-

-

121

-

-

-

-

-

-

-

-

-

15

-

-

-

-

-

-

-

-

-

1.97K

-

-

-

-

-

-

-

-

-

33.00
34.00
35.00
36.00
37.00
38.00
39.00
40.00
41.00
42.00
43.00
44.00
45.00
46.00
47.00
48.00
49.00
50.00
51.00
52.00
53.00
54.00
55.00
56.00
57.00
58.00
59.00
60.00

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

1

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

23

-

-

-

-

-

-

-

-

-

5

-

-

-

-

-

-

-

-

-

37

-

-

-

-

-

-

-

-

-

10

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

3

-

-

-

-

-

-

-

-

-

13

-

-

-

-

-

-

-

-

-

8

-

-

-

-

-

-

-

-

-

12

-

-

-

-

-

-

-

-

-

64

-

-

-

-

-

-

-

-

-

11

-

-

-

-

-

-

-

-

-

10

-

-

-

-

-

-

-

-

-

11

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

2

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

14

SRPTSarepta Therapeutics:60.700+1.210+2.03%

0

-

-

-

-

-

-

-

-

-

8

-

-

-

-

-

-

-

-

-

13

-

-

-

-

-

-

-

-

-

12

-

-

-

-

-

-

-

-

-

44

-

-

-

-

-

-

-

-

-

1

-

-

-

-

-

-

-

-

-

4

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

88

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

15

-

-

-

-

-

-

-

-

-

17

-

-

-

-

-

-

-

-

-

42

-

-

-

-

-

-

-

-

-

4

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

2

-

-

-

-

-

-

-

-

-

13

-

-

-

-

-

-

-

-

-

6

-

-

-

-

-

-

-

-

-

1

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

4

-

-

-

-

-

-

-

-

-

102

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

223

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

2

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

2

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

1

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

1

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

21

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

1

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

61.00
62.00
63.00
64.00
65.00
66.00
67.00
68.00
69.00
70.00
71.00
72.00
73.00
74.00
75.00
76.00
77.00
78.00
79.00
80.00
81.00
82.00
83.00
84.00
85.00
86.00
87.00
88.00
89.00
90.00
91.00
92.00
93.00
94.00
95.00
96.00
97.00
98.00
99.00
100.00
101.00
102.00
103.00
104.00
105.00
106.00
107.00
108.00
109.00
110.00
111.00
112.00
113.00
114.00
115.00
116.00
117.00
118.00
119.00
120.00
125.00
130.00
135.00
140.00
145.00
150.00
155.00
160.00

-

-

-

-

-

-

-

-

-

2

-

-

-

-

-

-

-

-

-

2

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

2

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

1

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

72

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

1

-

-

-

-

-

-

-

-

-

1

-

-

-

-

-

-

-

-

-

1

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

1

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

1

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

0

Market Insights

U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

No. Symbol Price
Broadcom
AVGO
185.978
Salesforce
CRM
262.680
Qualcomm
QCOM
145.850
4
Oracle
ORCL
136.235
5
Netflix
NFLX
1086.405
Log In for the Full List
Unlock Now

Investment Course

Top 5 Industries for Stock Trading under Trump's Second Term
Stocks & Industries to Watch Under Trump's Second Presidency
With mooomoo, find out which stocks and industries may benefit from Trump's second presidency, based on his first administration's track record.

Discussing

Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context, Show More
MicroStrategy Q4 2024 earnings conference call

Earnings Season Underway

Earnings season is here. What to know?